Ningbo David Medical Device Co Ltd (300314) — Net Asset Quality Index

Latest as of March 2026: 85.7%

Ningbo David Medical Device Co Ltd (300314) has a Net Asset Quality Index of 85.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.45 Billion minus total liabilities of CN¥208.08 Million yields net assets of CN¥1.24 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Ningbo David Medical Device Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Quality Index

85.7%
Equity / Total Assets

Net Assets

CN¥1.24 Billion
CNY

Total Assets

CN¥1.45 Billion
CNY

Total Liabilities

CN¥208.08 Million
CNY

Ningbo David Medical Device Co Ltd Net Asset Quality Index Over Time (2008–2025)

This chart shows how Ningbo David Medical Device Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 85.7%, representing net assets of CN¥1.24 Billion against total assets of CN¥1.45 Billion CNY. Explore Ningbo David Medical Device Co Ltd (300314) cash conversion ratio to assess how effectively this company generates cash.

Annual Net Asset Quality Index for Ningbo David Medical Device Co Ltd (2008–2025)

The table below presents the year-by-year Net Asset Quality Index for Ningbo David Medical Device Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Ningbo David Medical Device Co Ltd (300314) total market value.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 82.7% CN¥1.23 Billion CN¥1.49 Billion CN¥258.79 Million ▼ -0.2 pp
2024 82.9% CN¥1.17 Billion CN¥1.41 Billion CN¥241.77 Million ▼ -1.8 pp
2023 84.7% CN¥1.16 Billion CN¥1.37 Billion CN¥210.61 Million ▲ +0.1 pp
2022 84.6% CN¥1.06 Billion CN¥1.25 Billion CN¥193.39 Million ▼ -1.1 pp
2021 85.7% CN¥990.53 Million CN¥1.16 Billion CN¥165.36 Million ▲ +0.7 pp
2020 85.0% CN¥953.52 Million CN¥1.12 Billion CN¥168.62 Million ▼ -0.9 pp
2019 85.9% CN¥828.85 Million CN¥965.13 Million CN¥136.28 Million ▼ -3.6 pp
2018 89.5% CN¥792.71 Million CN¥885.85 Million CN¥93.13 Million ▼ -0.2 pp
2017 89.7% CN¥778.30 Million CN¥867.32 Million CN¥89.02 Million ▲ +0.5 pp
2016 89.2% CN¥748.55 Million CN¥839.03 Million CN¥90.48 Million ▼ -3.5 pp
2015 92.7% CN¥697.90 Million CN¥752.77 Million CN¥54.87 Million ▼ -0.4 pp
2014 93.1% CN¥668.97 Million CN¥718.75 Million CN¥49.78 Million ▼ -0.1 pp
2013 93.1% CN¥628.16 Million CN¥674.54 Million CN¥46.38 Million ▲ +1.9 pp
2012 91.2% CN¥592.09 Million CN¥649.19 Million CN¥57.10 Million ▲ +31.6 pp
2011 59.6% CN¥164.25 Million CN¥275.73 Million CN¥111.48 Million ▲ +13.0 pp
2010 46.6% CN¥110.28 Million CN¥236.89 Million CN¥126.61 Million ▲ +7.8 pp
2009 38.7% CN¥79.57 Million CN¥205.35 Million CN¥125.79 Million ▼ -4.2 pp
2008 43.0% CN¥82.46 Million CN¥191.91 Million CN¥109.45 Million
pp = percentage points